These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 1328851)

  • 1. The MRF4 activation domain is required to induce muscle-specific gene expression.
    Mak KL; To RQ; Kong Y; Konieczny SF
    Mol Cell Biol; 1992 Oct; 12(10):4334-46. PubMed ID: 1328851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential trans activation associated with the muscle regulatory factors MyoD1, myogenin, and MRF4.
    Yutzey KE; Rhodes SJ; Konieczny SF
    Mol Cell Biol; 1990 Aug; 10(8):3934-44. PubMed ID: 1695319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4.
    Valdez MR; Richardson JA; Klein WH; Olson EN
    Dev Biol; 2000 Mar; 219(2):287-98. PubMed ID: 10694423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle-specific expression of the troponin I gene requires interactions between helix-loop-helix muscle regulatory factors and ubiquitous transcription factors.
    Lin H; Yutzey KE; Konieczny SF
    Mol Cell Biol; 1991 Jan; 11(1):267-80. PubMed ID: 1846022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of MRF4, a myogenic helix-loop-helix protein, produces multiple changes in the myogenic program of BC3H-1 cells.
    Block NE; Miller JB
    Mol Cell Biol; 1992 Jun; 12(6):2484-92. PubMed ID: 1588952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Domains outside of the DNA-binding domain impart target gene specificity to myogenin and MRF4.
    Chakraborty T; Olson EN
    Mol Cell Biol; 1991 Dec; 11(12):6103-8. PubMed ID: 1658626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ras p21Val inhibits myogenesis without altering the DNA binding or transcriptional activities of the myogenic basic helix-loop-helix factors.
    Kong Y; Johnson SE; Taparowsky EJ; Konieczny SF
    Mol Cell Biol; 1995 Oct; 15(10):5205-13. PubMed ID: 7565669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of MRF4: a new member of the muscle regulatory factor gene family.
    Rhodes SJ; Konieczny SF
    Genes Dev; 1989 Dec; 3(12B):2050-61. PubMed ID: 2560751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myf5, MyoD, myogenin and MRF4 myogenic derivatives of the embryonic mesenchymal cell line C3H10T1/2 exhibit the same adult muscle phenotype.
    Auradé F; Pinset C; Chafey P; Gros F; Montarras D
    Differentiation; 1994 Feb; 55(3):185-92. PubMed ID: 8187980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mouse MRF4 promoter is trans-activated directly and indirectly by muscle-specific transcription factors.
    Black BL; Martin JF; Olson EN
    J Biol Chem; 1995 Feb; 270(7):2889-92. PubMed ID: 7852366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of muscle differentiation by the adenovirus E1a protein: repression of the transcriptional activating function of the HLH protein Myf-5.
    Braun T; Bober E; Arnold HH
    Genes Dev; 1992 May; 6(5):888-902. PubMed ID: 1315706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MyoD and myogenin act on the chicken myosin light-chain 1 gene as distinct transcriptional factors.
    Asakura A; Fujisawa-Sehara A; Komiya T; Nabeshima Y; Nabeshima Y
    Mol Cell Biol; 1993 Nov; 13(11):7153-62. PubMed ID: 8413304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle regulatory factor MRF4 activates differentiation in rhabdomyosarcoma RD cells through a positive-acting C-terminal protein domain.
    Sirri V; Leibovitch MP; Leibovitch SA
    Oncogene; 2003 Aug; 22(36):5658-66. PubMed ID: 12944914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential trans-activation of a muscle-specific enhancer by myogenic helix-loop-helix proteins is separable from DNA binding.
    Chakraborty T; Brennan T; Olson E
    J Biol Chem; 1991 Feb; 266(5):2878-82. PubMed ID: 1847137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myogenin and MEF2 function synergistically to activate the MRF4 promoter during myogenesis.
    Naidu PS; Ludolph DC; To RQ; Hinterberger TJ; Konieczny SF
    Mol Cell Biol; 1995 May; 15(5):2707-18. PubMed ID: 7739551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the muscle regulatory factor MRF4 during somite and skeletal myofiber development.
    Hinterberger TJ; Sassoon DA; Rhodes SJ; Konieczny SF
    Dev Biol; 1991 Sep; 147(1):144-56. PubMed ID: 1715299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cAMP-dependent protein kinase represses myogenic differentiation and the activity of the muscle-specific helix-loop-helix transcription factors Myf-5 and MyoD.
    Winter B; Braun T; Arnold HH
    J Biol Chem; 1993 May; 268(13):9869-78. PubMed ID: 8387507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel MyoD gene targets in proliferating myogenic stem cells.
    Wyzykowski JC; Winata TI; Mitin N; Taparowsky EJ; Konieczny SF
    Mol Cell Biol; 2002 Sep; 22(17):6199-208. PubMed ID: 12167713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor inhibits MRF4 activity independently of the phosphorylation status of a conserved threonine residue within the DNA-binding domain.
    Hardy S; Kong Y; Konieczny SF
    Mol Cell Biol; 1993 Oct; 13(10):5943-56. PubMed ID: 8413199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E-box- and MEF-2-independent muscle-specific expression, positive autoregulation, and cross-activation of the chicken MyoD (CMD1) promoter reveal an indirect regulatory pathway.
    Dechesne CA; Wei Q; Eldridge J; Gannoun-Zaki L; Millasseau P; Bougueleret L; Caterina D; Paterson BM
    Mol Cell Biol; 1994 Aug; 14(8):5474-86. PubMed ID: 8035824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.